Roche’s changing plans show how MFN is complicating European drug launches - Endpoints News

Fecha de publicación: 26 de octubre de 2026, 16:06

Roche’s changing plans show how MFN is complicating European drug launches Endpoints News Update on Foreign Freeloading on U.S. Drug Innovation RealClearHealth MFN Drug Policy Cuts US Costs; It May Block Europe’s First Sjögren’s Therapy Tech Times EU ministers and pharma lobbies meet in Dublin to…